
        Irving V. Sollins, a researcher in steroids and oral contraceptives and an entrepreneur in the pharmaceutical industry, died on Monday at his home in Rye, N.Y. He was 82 years old.
        He died of a heart attack, his family said.
        Dr. Sollins was active in the pharmaceutical industry from the end of World War II until his death. Since 1983 he had been president and chief executive officer of Ivy Laboratories, Inc., of Overland Park, Kan., a producer of veterinary products.
        From 1946 until 1952 he was chief executive of Syntex, Inc., where he supervised the synthesis of various steroid hormones and compounds and developed their applications for clinical and public-health uses.
        Dr. Sollins held bachelor's, master's and doctoral degrees from New York University and served with the United States Public Health Service from 1937 to 1946. In the latter stages of World War II he directed rebuilding of the pharmaceutical and medical-supply industries in Europe and Asia for the United Nations Relief and Rehabilitation Administration.
        In the late 1960's and early 1970's, Dr. Sollins developed enzyme products in this country and in the late 70's he acquired and became chairman of the Generic Pharmaceutical Corporation.
        His wife, the former Sonya Peretz, died in 1983. He is surived by a son, James, of Washington; two daughters, Susan Brown and Marybeth Sollins, both of Rye, and two grandsons.
      